en/health – 5. oldal
- Weight-Loss Trends in 2026: GLP-1 Drugs, Low-Carb Myths, OMAD, and the Hidden Risks of “Herbal” Supplements 2026-03-12
GLP-1 weight-loss medicines are expanding rapidly, while diet trends like extreme low-carb and OMAD keep circulating. Here’s what the latest headlines suggest—and how to approach weight loss safely and realistically.
- Weight-loss drugs in 2026: Why coaching, pricing, and access are reshaping results 2026-03-12
GLP-1 weight-loss medications are evolving beyond prescriptions: coaching programs, new formulations, and pricing incentives are changing how people start—and stick with—treatment. Here’s what the latest headlines suggest for patients and everyday health choices.
- Why Weight Often Returns After Stopping GLP-1 Drugs—and How to Keep Results Longer 2026-03-12
Many people regain a significant portion of weight after stopping GLP-1 medications. Learn why it happens and what evidence-informed habits and support can improve long-term success.
- GLP-1 Weight-Loss Drugs in 2026: Better Coaching, New Safety Questions, and Tighter Ad Rules 2026-03-12
GLP-1 medications are reshaping obesity care, but 2026 headlines highlight a broader shift: smarter feedback systems, the value of coaching, emerging safety signals, and stricter marketing oversight.
- GLP-1 Weight Loss in 2026: New Programs, Better Feedback, and Emerging Safety Questions 2026-03-12
GLP-1 medications are reshaping weight management, but success increasingly depends on coaching, data-driven feedback, and careful safety monitoring. Here’s what recent reporting suggests about where programs are headed—and what patients should ask.
- Weight Loss in 2026: What New Research Says About Fasting, GLP-1 Drugs, and Sustainable Results 2026-03-11
New headlines challenge some popular weight-loss approaches while highlighting emerging solutions and overlooked risks. Here’s a practical, research-informed guide to what may matter most for long-term health and weight management in 2026.
- Weight Loss in 2026: Managing Night Cravings, Biohacking Basics, and the New Telehealth Drug Landscape 2026-03-11
A practical guide to reducing late-night hunger, using evidence-aligned “biohacking” habits safely, and understanding how telehealth and new weight-loss medications are changing care.
- Weight Loss in 2026: What Actually Works (Habits, Hunger Control, and the New Medication Landscape) 2026-03-11
From managing late-night cravings to understanding the fast-changing world of weight-loss medications, here’s a practical, evidence-minded guide to sustainable progress. Learn what to prioritize, what to be cautious about, and how to build a plan you can keep.
- GLP-1 Weight-Loss Drugs in 2026: Long-Term Strategies, New Add-Ons, and Emerging Safety Questions 2026-03-11
GLP-1 medications are reshaping obesity care, but long-term weight maintenance, rebound appetite, and new safety signals are driving changes in how these drugs are used and monitored.
- GLP-1 Weight-Loss Drugs: What New Reports Suggest About Eye Risks, Long-Term Use, and Safety Oversight 2026-03-11
Recent headlines link some GLP-1 weight-loss medicines to rare but serious vision events while also exploring how treatment changes may affect long-term weight management. Here’s what the reports suggest, what remains uncertain, and how to reduce risk with your clinician.